Skip to content

Assessment of Quality of life among the chronic kidney disease patients on haemodialysis

Pharmaceutical care intervention and health related quality of life (HRQoL) among the chronic kidney disease patients on haemodialysis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/040779
Enrollment
140
Registered
2022-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N186- End stage renal disease

Interventions

Intervention1: Pharmacists Intervention to HD patients for 9 Months: Patient will be counseled by using various suitable education materials like patient information leaflets for once in every three m

Sponsors

Ruhul Amin
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All HD Patients . Patients age > 18 years Interested people who are willingly participate in this research study. Ability to speak and understand the language Do not suffer from psychiatric diseases Being conscious and cooperative

Exclusion criteria

Exclusion criteria: Patients age Cancer patients HIV/AIDs Patients SLE patients Patients who declined to answer the questionnaire Those who had voluntarily withdrawn from dialysis Those with severe illness or psychosis, and pregnant and lactating women were excluded Patients suffering from hearing and speech problems.

Design outcomes

Primary

MeasureTime frame
Health related quality of life, KDQOL-SF36Timepoint: Baseline, 3 months and 6 months

Secondary

MeasureTime frame
Medication adherence, CKD-HD knowledge levelTimepoint: baseline, 3rd Month and 6th Month

Countries

India

Contacts

Public ContactRuhul Amin

Assam down town University

ruhulglp18@gmail.com7002942887

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026